| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥61.6B | ¥55.6B | +10.9% |
| Operating Income | ¥1.9B | ¥-0.8B | +346.7% |
| Ordinary Income | ¥2.5B | ¥-1.1B | +335.5% |
| Net Income | ¥3.9B | ¥-1.9B | +301.4% |
| ROE | 18.9% | -12.5% | - |
FY2026 Q3 results showed Revenue of 61.6B yen (YoY +10.9%), Operating Income of 1.9B yen (prior period loss of -0.8B yen, YoY +346.7%), Ordinary Income of 2.5B yen (prior loss of -1.1B yen, YoY +335.5%), and Net Income of 3.9B yen (prior loss of -1.9B yen, YoY +301.4%). The company achieved a turnaround to profitability across all profit lines. Operating margin improved to 3.0% from prior period negative territory, while gross profit margin remained strong at 45.0%. Extraordinary income of 3.0B yen, primarily from business divestiture gains, significantly contributed to the profit expansion. The company maintained zero dividend policy for the full year.
Revenue increased 10.9% YoY to 61.6B yen, driven by growth in the Massage Franchise segment (+19.1% YoY) and stable performance in Massage Direct operations (+4.5% YoY). The Medical Care segment revenue decreased -2.1% YoY to 21.1B yen, reflecting ongoing business reorganization. Gross profit of 27.7B yen maintained a healthy margin of 45.0%, indicating strong pricing power and service value. However, SG&A expenses of 25.9B yen represented 42.0% of revenue, compressing operating margin to 3.0%.
Operating income turned positive at 1.9B yen versus prior period loss of -0.8B yen, marking a significant operational improvement. Non-operating income contributed 0.7B yen net (1.7B yen income versus 1.0B yen expenses including 0.9B yen interest expense), lifting Ordinary Income to 2.5B yen. The gap between Ordinary Income of 2.5B yen and Net Income of 3.9B yen reflects extraordinary income of 3.0B yen, primarily business divestiture gains. This non-recurring factor substantially boosted bottom-line performance. Income tax expense of 1.6B yen represented an effective tax rate of approximately 29% against pre-tax profit of 5.5B yen.
This represents a "revenue up / profit up" pattern, with both top-line growth and turnaround to profitability. However, the profit improvement relies significantly on non-recurring extraordinary gains rather than pure operational leverage.
Massage Direct segment generated revenue of 31.5B yen (+4.5% YoY) with operating income of 9.1B yen and margin of 29.0%, representing the core business and largest revenue contributor. Massage Franchise segment posted revenue of 8.9B yen (+19.1% YoY) with operating income of 2.6B yen and margin of 29.1%, matching the Direct segment's profitability while showing stronger growth momentum. Medical Care segment recorded revenue of 21.1B yen (-2.1% YoY) with operating loss of -2.0B yen (margin -9.5%), reflecting ongoing restructuring challenges as the company consolidates home-visit nursing services into this segment. Corporate costs of 7.9B yen not allocated to segments compressed consolidated operating margin despite strong segment-level profitability in the two massage businesses. The restructuring of Medical Care and integration of previously separate segments represents a strategic realignment toward profitability.
[Profitability] ROE of 18.9% reflects high financial leverage and turnaround to profitability, though substantially supported by extraordinary gains. Operating margin of 3.0% improved from prior loss position but remains constrained by high SG&A burden at 42.0% of revenue. Net profit margin of 6.3% was elevated by non-recurring gains. Gross profit margin of 45.0% demonstrates solid underlying service economics. [Cash Quality] Cash and deposits increased 94.7% YoY to 15.9B yen, providing short-term debt coverage of 1.67x against current portion of debt. [Investment Efficiency] Asset turnover of 1.076 indicates efficient asset utilization, supported by asset-light business model post-restructuring. Receivables turnover reflects DSO of 76 days, indicating extended collection periods that warrant monitoring. [Financial Health] Equity ratio of 36.0% shows moderate capitalization with financial leverage of 2.78x. Current ratio of 204.8% indicates adequate short-term liquidity, though current liabilities represent 70.2% of total liabilities, concentrating refinancing risk in the near term.
Cash and deposits increased 8.2B yen YoY to 15.9B yen, substantially improving liquidity position. This cash accumulation coincides with fixed asset reduction of 34.3B yen (-84.1%), intangible asset reduction of 2.8B yen (-43.8%), and goodwill reduction of 2.4B yen (-61.6%), suggesting significant asset monetization and business divestiture activities generating cash inflows. The increase in retained earnings of 3.9B yen aligns with net income generation. Working capital dynamics show trade receivables at 12.8B yen with extended collection cycle of 76 days. Short-term liquidity remains adequate with cash coverage of 1.67x against current debt obligations of 9.5B yen. The balance sheet restructuring with substantial fixed asset reduction and cash accumulation positions the company with improved near-term financial flexibility, though ongoing management of working capital efficiency and debt refinancing remains critical.
Ordinary Income of 2.5B yen versus Operating Income of 1.9B yen reflects net non-operating contribution of 0.6B yen, primarily from non-operating income of 1.7B yen offset by interest expense of 0.9B yen. Extraordinary income of 3.0B yen from business divestitures represents 48.7% of revenue, constituting a material non-recurring factor. This extraordinary gain substantially elevated pre-tax profit to 5.5B yen from the operating base of 1.9B yen. The reliance on non-recurring gains of 3.0B yen versus operating income of 1.9B yen raises earnings quality concerns, as sustainable profitability depends on core operations generating higher margins. Interest expense of 0.9B yen against interest-bearing debt of 13.5B yen implies an average interest rate of approximately 6.7% annualized, representing material financing costs that compress ordinary income. Without cash flow statement data, assessment of cash-backed earnings cannot be directly verified, though the substantial cash balance increase of 8.2B yen YoY suggests some degree of cash generation capability.
Against full-year guidance of Revenue 77.2B yen and Operating Income 2.9B yen, Q3 cumulative progress shows Revenue at 79.8% and Operating Income at 63.8% through nine months. Revenue progress slightly exceeds the standard 75% Q3 benchmark, suggesting potential for upside or conservative full-year guidance. Operating Income progress of 63.8% trails the standard 75% benchmark by 11.2 percentage points, though the extraordinary gains contributing to bottom-line results are not reflected in operating income guidance. The company maintained its forecast without revision this quarter. Full-year EPS forecast of 155.49 yen compares to Q3 cumulative actual EPS of 150.27 yen, implying Q4 EPS of approximately 5 yen, suggesting modest Q4 earnings contribution after the Q3 extraordinary gains. The forecast assumes zero dividend for full year, maintaining no shareholder distribution policy.
The company forecasts zero dividend for the full year, maintaining its no-dividend policy. With net income of 3.9B yen in Q3 cumulative, the absence of dividend despite return to profitability indicates prioritization of cash retention for business operations or debt reduction. Payout ratio is 0% with no indication of shareholder distribution plans. No share buyback activities are disclosed. Total return ratio to shareholders remains 0%. The substantial cash balance increase to 15.9B yen and return to profitability have not translated into shareholder returns, suggesting management focus on financial stability and reinvestment over distributions in the current phase.
Earnings sustainability risk: Operating margin of 3.0% remains low relative to gross margin of 45.0% due to SG&A burden of 42.0%, and Q3 profitability relied heavily on extraordinary gains of 3.0B yen which are non-recurring. Without sustained operational margin improvement, future profitability may revert toward breakeven levels. Refinancing risk concentration: Short-term liabilities represent 70.2% of total liabilities at 21.8B yen, with current debt obligations of 9.5B yen requiring near-term refinancing or repayment. While current ratio of 204.8% provides coverage, extended maturities or refinancing on unfavorable terms could pressure liquidity. Medical Care segment restructuring execution: The segment posted operating loss of -2.0B yen with -9.5% margin, and successful turnaround requires effective integration of consolidated services and achievement of profitability, which remains uncertain given ongoing business reorganization.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 18.9% substantially exceeds industry median of 8.3%, though this outperformance reflects high financial leverage of 2.78x versus industry median of 1.66x and material extraordinary gain contribution. Operating margin of 3.0% significantly underperforms industry median of 8.2%, indicating operational efficiency challenges despite turnaround from loss position.
Financial Health: Equity ratio of 36.0% falls below industry median of 59.2%, reflecting higher leverage strategy. Current ratio of 204.8% approximates industry median of 2.15x, suggesting comparable short-term liquidity positioning.
Efficiency: Asset turnover of 1.076 exceeds industry median of 0.67, demonstrating superior asset efficiency following asset restructuring. Receivables turnover of 76 days compares to industry median of 61 days, indicating somewhat extended collection periods. Net profit margin of 6.3% aligns with industry median of 6.0%, though extraordinary gains elevated this metric above sustainable levels.
Growth: Revenue growth of 10.9% YoY slightly exceeds industry median of 10.4%, positioning in the upper half of peer performance.
The company exhibits higher leverage, lower operating margins, and superior asset efficiency compared to industry norms, with recent profitability improvement substantially influenced by non-recurring factors rather than operational excellence.
(Industry: IT & Telecommunications Services, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Return to profitability with operating leverage improvement: The company achieved turnaround from operating loss of -0.8B yen to operating income of 1.9B yen, demonstrating operational recovery despite low 3.0% margin. Sustained margin expansion beyond current levels remains the key threshold for durable profitability given the 42.0% SG&A burden against 45.0% gross margin.
Balance sheet restructuring and liquidity enhancement: Substantial fixed asset reduction of 34.3B yen (-84.1%) and cash increase of 8.2B yen (+94.7%) reflect strategic asset monetization and business divestiture, improving near-term financial flexibility. However, short-term debt concentration at 70.2% of total liabilities creates refinancing requirements that necessitate continued cash preservation or favorable credit market access.
Medical Care segment transformation as profitability catalyst: The -2.0B yen operating loss in Medical Care with -9.5% margin represents both the primary profitability drag and the largest improvement opportunity. Successful restructuring and integration of consolidated home-visit nursing services could materially improve consolidated margins, while execution shortfall could offset gains in the profitable massage segments.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.